6) Human and mouse SAP cDNAs and genomic DNAs were isolated. The deduced amino acid sequence of human SAP is highly homologous with that of mouse SAP.
Collagen is one of the major components of extracellular matrix. There arc 13 different types of collagen molecules, and at least 24 genetically distinct subunit chains.
Characteristic clinical features of collagen metabolism disorders are deformities of skeleton, bone fracture, fragility and hyperextensibility of skin, joint hypermobility, easy bruisability, venous varicosities, hernia and ocular fragility. Collagen metabolism disorders include Ehlers-Danlos syndrome (ED), osteogenesis imperfecta (OI) and Marfan syndrome (MF). ED and OI show large heterogeneity in clinical manifestations. Recent advances of collagen metabolism revealed that pathogenesis of ED are considered to be abnormalities of biosynthetic processes of type I and III procollagen or that of maturation of type I collagen fibers with a few exceptional variants, and that of OI are type I procollagen gene mutations. On the other hand, in spite of researches about one MF variant who showed insertion of about 20 amino acids in a2(I)-CB5 of type I collagen, underlying defects in connective tissues of MF is still unclear.
One of the characteristic features of osteogenesis imperfecta with collagen gene mutations depend on triple herical structure of type I collagen molecule, which is composed with two al(I) chain and one a2(I) chain. When cultured fibroblasts from the patients synthesized approximately equal amounts of normal proal(I) chains and of shortened proal(I) chains (mutant proteins), one-half of the trimers assembled in cells contained one shortened proal(I) chains and one-quarter contained two shortened proal(I) chains. The trimers containing the shortened proal(I) chains, however, were metabolically unstable. They folded into a triple-helical conformation only at temperatures well below body temperature. The phenomenon, which has been referred to as "protein suicide," created a situation in which the total amount of biologically useful type I procollagen produced by fibroblasts was reduced to one-quarter of the control.
We analyzed collagens produced by skin fibroblasts from a patient with a lethal form variant of osteogenesis imperfecta (OI-type II). They synthesized equal amount of two proal(I) chain, one was normal and the other was shortened chain. CNBr peptide mapping, animal collagenase digestion revealed that the mutation location of the shortened proal(I) chain existed in CBS-peptide. In addition to the mutation of proal(1) chain, there was elevated synthesis of type IV and V collagen. These results indicated that alteration of collagen metabolism occurred in the disease.
